Metoprolol
KAPSPARGO, LOPRESSOR, Metoprolol, TOPROL, TOPROL XL
Beta-Adrenergic Blocker
NADAC/unit
$0.0171
No Shortage
Tier 1: 734.7%
31 Manufacturers
98 ANDAs
Metoprolol tartrate tablets are a beta-adrenergic blocker indicated for the treatment of: Hypertension, to lower blood pressure.
vs. brand KAPSPARGO: Generic saves up to 100% per unit
Active Shortages
2025-06-03 Permanent discontinuation in the manufacturing of the drug, Aurobindo Pharma USA
2025-06-03 Permanent discontinuation in the manufacturing of the drug, Aurobindo Pharma USA
2025-06-03 Permanent discontinuation in the manufacturing of the drug, Aurobindo Pharma USA
2025-06-03 Permanent discontinuation in the manufacturing of the drug, Aurobindo Pharma USA
2025-06-03 Permanent discontinuation in the manufacturing of the drug, Aurobindo Pharma USA
Market Intelligence
2026-03-11 Class II Recall: Teva Pharmaceuticals USA, Inc
2026-03-11 Class II Recall: Teva Pharmaceuticals USA, Inc
2026-03-11 Class II Recall: Teva Pharmaceuticals USA, Inc
2026-03-11 Class II Recall: Teva Pharmaceuticals USA, Inc
2025-08-20 Class II Recall: Westminster Pharmaceuticals LLC
Generic Manufacturers
ACTAVIS ELIZABETH LLCACTAVIS LABORATORIES FL INCALEMBIC PHARMACEUTICALS LTDALKEM LABORATORIES LTDAUROBINDO PHARMA LTDBAXTER HEALTHCARE CORPCIPLA LTDDOCTOR REDDYS LABORATORIES LTDDR REDDYS LABORATORIES LTDFRESENIUS KABI USA LLCGLAND PHARMA LTDGRANULES INDIA LTDHETERO LABS LTD UNIT IIIHIKMA FARMACEUTICA (PORTUGAL) SAHIKMA PHARMACEUTICALS USA INCHOSPIRA INCIPCA LABORATORIES LTDMELINTA THERAPEUTICS LLC A WHOLLY OWNED SUB OF CORMEDIX INCMYLAN PHARMACEUTICALS INCNOVAST LABORATORIES LTDPHARMADAX INCRENATA PLCRUBICON RESEARCH LTDSANDOZ INCSCIEGEN PHARMACEUTICALS INCSUN PHARMA INDUSTRIES LTDSUN PHARMACEUTICAL INDUSTRIES INCSUNSHINE LAKE PHARMA CO LTDVALIDUS PHARMACEUTICALS LLCVISUM PHARMACEUTICAL CO LTDWOCKHARDT BIO AGXTM CONSULTING LLCYICHANG HUMANWELL PHARMACEUTICAL CO LTDZHEJIANG JUTAI PHARMACEUTICAL CO LTDZYDUS PHARMACEUTICALS USA INC
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.